Knight Therapeutics Inc. (TSX:GUD)

Knight Therapeutics Ratios and Metrics

Market cap in millions CAD. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 26, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Cap	801	600	534	525	581	624
Market Cap Growth	41.57%	12.33%	1.73%	-9.66%	-6.89%	-8.22%
Enterprise Value	727.74	579.27	438.66	438.02	498.84	514.09
Last Close Price	8.16	6.05	5.34	5.19	5.18	5.30
PE Ratio	144.39	-	133.50	-	-	40.77
Forward PE	66.61	201.67	157.06	79.24	-	82.43
PS Ratio	1.57	1.33	1.44	1.60	1.98	2.56
PB Ratio	1.02	0.78	0.67	0.70	0.70	0.74
P/TBV Ratio	1.03	0.79	0.68	0.75	0.72	0.78
P/FCF Ratio	7.92	8.95	15.80	15.01	13.80	15.31
P/OCF Ratio	7.56	8.70	14.72	14.61	12.92	13.99
EV/Sales Ratio	1.43	1.29	1.18	1.33	1.70	2.11
EV/EBITDA Ratio	9.84	10.68	7.25	9.22	23.12	14.65
EV/EBIT Ratio	52.87	-	59.30	-	-	-
EV/FCF Ratio	7.20	8.64	12.97	12.52	11.84	12.60
Debt / Equity Ratio	0.08	0.10	0.06	0.09	0.09	0.05
Debt / EBITDA Ratio	0.93	1.44	0.82	1.45	3.60	1.17
Debt / FCF Ratio	0.69	1.16	1.46	1.98	1.85	1.00
Net Debt / Equity Ratio	-0.07	-0.02	-0.12	-0.11	-0.10	-0.13
Net Debt / EBITDA Ratio	-0.77	-0.32	-1.53	-1.80	-3.70	-3.09
Net Debt / FCF Ratio	-0.57	-0.26	-2.75	-2.44	-1.89	-2.66
Asset Turnover	0.48	0.45	0.39	0.33	0.29	0.24
Inventory Turnover	1.99	2.09	2.02	1.90	1.89	1.99
Quick Ratio	1.45	1.39	2.26	2.20	1.87	1.99
Current Ratio	2.32	2.39	3.57	3.20	2.80	2.90
Return on Equity (ROE)	0.72%	-0.69%	0.56%	-2.14%	-3.58%	-1.81%
Return on Assets (ROA)	1.66%	-0.23%	0.77%	-0.29%	-4.01%	-1.26%
Return on Invested Capital (ROIC)	2.15%	-0.30%	1.02%	-0.39%	-5.23%	-1.84%
Return on Capital Employed (ROCE)	1.55%	-0.27%	0.88%	-0.33%	-4.56%	-1.42%
Earnings Yield	0.70%	-	0.75%	-	-	2.45%
FCF Yield	12.62%	11.17%	6.33%	6.66%	7.25%	6.53%
Buyback Yield / Dilution	1.86%	1.84%	5.61%	6.46%	7.74%	5.65%
Total Shareholder Return	1.86%	1.84%	5.61%	6.46%	7.74%	5.65%

Updated May 7, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.